← Back to all trials
Not Yet Recruiting
NCT05688358
Serum Interleukin - 17A in Juvenile Idiopathic Arthritis
Conditions: JIA
Sex: All
Ages: N/A – 16 Years
Enrollment: 78
Sponsor: Assiut University
Summary
This study aims to determine the serum levels of interleukin-17A (IL-17A) in children with juvenile idiopathic arthritis (JIA)Analyze the correlation between IL-17A values and disease activity, certain clinical features, and laboratory markers of inflammation.
Eligibility Criteria
Inclusion Criteria:_ Patients less than 16 years at onset of disease and diagnosed with oligoarticular and polyarticular JIA, fulfilling the ILAR classificationcriteria of JIA.Control group will include age-and-sex-matched apparently healthy children.Exclusion Criteria: • Patients having associated neurological or disabling diseases.Patients with diabetes mellitus, acute or chronic infections.Patients with another causes of arthritis other than JIA.
Source: ClinicalTrials.gov (NCT05688358). StuddyBuddy aggregates publicly available trial information.
